stage

AIN
Gena Health (Gena)

Gena Health (Gena)

location_on London ,  United Kingdom

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

We connect cancer patients to personalised treatment options which go beyond the standard of care. Framed another way - we are building the infrastructure behind precision medicine.

Highlights

  • We have a working testable prototype and MVP to be released in June '25
  • 1x Biopharma design partner in GSK
  • We have over 1000 patients signed up on our waiting list
  • We have 3x treatment providers who will be our launch partners
  • Backed by multiple accelerators expanding our presence across Europe

Overview

Target $900,000
Minimum $15,000
Investment Raised $150,000
Previous Rounds $0
Stage Pre-Startup/R&D
Investor Role Any

Ask a question
Got a question about this project?

Similar Projects

Loading…
Loading the web debug toolbar…
Attempt #